1. Home
  2. MRAM vs AVXL Comparison

MRAM vs AVXL Comparison

Compare MRAM & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Everspin Technologies Inc.

MRAM

Everspin Technologies Inc.

HOLD

Current Price

$13.21

Market Cap

327.8M

Sector

Technology

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$3.27

Market Cap

289.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRAM
AVXL
Founded
2008
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
327.8M
289.1M
IPO Year
2016
2013

Fundamental Metrics

Financial Performance
Metric
MRAM
AVXL
Price
$13.21
$3.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$14.00
$22.00
AVG Volume (30 Days)
457.9K
1.0M
Earning Date
04-29-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$49,417,000.00
N/A
Revenue This Year
$10.22
N/A
Revenue Next Year
$7.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
37.51
N/A
52 Week Low
$5.34
$2.61
52 Week High
$17.24
$13.99

Technical Indicators

Market Signals
Indicator
MRAM
AVXL
Relative Strength Index (RSI) 63.72 44.61
Support Level $8.22 $2.93
Resistance Level $15.93 $3.76
Average True Range (ATR) 0.80 0.20
MACD 0.16 0.04
Stochastic Oscillator 69.04 43.53

Price Performance

Historical Comparison
MRAM
AVXL

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a manufacturer of Magnetoresistive Random Access Memory (MRAM) technology. The company manufactures MRAM products using both captive and third-party manufacturing capabilities. It purchases industry-standard complementary metal-oxide semiconductor (CMOS) wafers from semiconductor foundries and perform back end of line (BEOL) processing that includes magnetic-bit technology at leased 200mm fabrication facility in Chandler, Arizona. It also manufactures full-flow 300mm CMOS wafers with STT-MRAM magnetic-bit technology integrated in BEOL. The company's customers are in key markets, such as industrial, medical, automotive/transportation, aerospace, and data center.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: